Senior Analytical scientist
Zealandpharma
·Today
- Location
- Sydmarken 11, Denmark
- Workplace
- Onsite
- Type
- Full-time
- Department
- Education
- Seniority
- Senior
- Education
- PhD
- Closing date
- Today
- Source
- Workday
Description
Does it excite you to work with late-stage analytical development of innovative peptide-based medicines, and do you have experience in analytical science? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As Senior Analytical Scientist, you will play a key role in late-stage analytical development across Development and Life Cycle Management (LCM) projects. Close collaboration with Contract Development and Manufacturing Organizations (CDMOs) is central to the position, making effective coordination with external partners an important part of your day-to-day work.
We offer exciting responsibilities:
- Take responsibility for analytical late-stage development and support activities in Development and LCM projects
- Support Drug Substance and Drug Product development with analytical expertise, including stability programs, specifications, extractables and leachable studies, in-use studies, and characterization
- Manage the collaboration with CDMOs, including oversight plan follow-up, day-to-day communication, method transfer and validation, and technical and QC support
- Author scientific reports and documentation that meet requirements for pharmaceutical products
- Provide scientific input to regulatory documents (NDA/MAA) in collaboration with colleagues at Zealand Pharma and CDMOs
- Contribute actively to the CMC team, driving project progress towards regulatory approval
Your profile
We are looking for someone with an analytical mindset who takes ownership and communicates clearly across teams. You are a proactive problem-solver with a friendly approach, strong collaboration skills, and a genuine enjoyment of continuous learning.
- M.Sc. or PhD in chemistry, biochemistry, pharmaceutical sciences, or a related field
- Several years of experience in the pharmaceutical industry within analytical science or QC
- Experience with late-stage analytical development, validation, and LCM support, preferably for peptide-based products
- Knowledge of GMP and regulatory aspects of analytical CMC development
- Experience with outsourcing to CMOs and CROs
- Experience in cross-functional project teams, with strong collaboration, stakeholder management skills
Your new team
You will join a highly experienced team in Analytical Development. We value a collaborative and supportive atmosphere in which great results are achieved together.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Interested in bonding with us? Then please apply no later than November 30, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
For further information, please contact Director, Head of Analytical Development, Iben Almar Meier; [email protected].
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com.
#LI-Onsite